| Dr Charles E Mccannon, MD | |
|
2501 Oakington St, Aberdeen Proving Ground, MD 21005-5131 | |
| (410) 278-1902 | |
| Not Available |
| Full Name | Dr Charles E Mccannon |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 2501 Oakington St, Aberdeen Proving Ground, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477623163 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | D0048190 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles E Mccannon, MD 1210 Stafford Rd, Darlington, MD 21034-1806 Ph: (410) 457-0460 | Dr Charles E Mccannon, MD 2501 Oakington St, Aberdeen Proving Ground, MD 21005-5131 Ph: (410) 278-1902 |
News Archive
Researchers have analyzed this evolution of the virus based on evolutionary ecology theory. Using the virus genomes available in the Global Initiative on Sharing Avian Influenza Data (GISAID) database, the researchers focused their inquiry on mutations in the receptor-binding domain (RBD) on the spike protein of SARS-CoV-2.
Immutep S.A., the biopharmaceutical company specializing in immuno-oncology, and Eddingpharm have entered into an agreement regarding the development, commercialization and manufacturing of Immutep's ImmuFact IMP321.
Collaborations between Johns Hopkins and National Taiwan University researchers have successfully manipulated the life span of common, single-celled yeast organisms by figuring out how to remove and restore protein functions related to yeast aging.
Antibiotic resistance is a major problem worldwide and there is an urgent need for new antibiotics to be developed. Potential new drugs are usually made in the lab which is complicated and time-consuming.
Shire plc today announced it has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration for its investigational candidate, lifitegrast, for the treatment of signs and symptoms of dry eye disease in adults. Shire resubmitted the NDA in response to the complete response letter (CRL) the company received from the FDA on October 16, 2015.
› Verified 7 days ago
Dr. Michael Earl Parker, M.D,M.P.H. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 5183 Black Hawk Rd, 20th Support Cmd, Afcb-md (attn: Surgeon), Aberdeen Proving Ground, MD 21010 Phone: 410-436-4603 | |
Dr. Kevin P. Michaels, M.D., MPH Preventive Medicine Medicare: Medicare Enrolled Practice Location: Kirk U.s. Army Health Clinic, 2501 Oakington St, Aberdeen Proving Ground, MD 21005 Phone: 410-278-1724 | |
Dr. Michael John Superior, MD, MPH Preventive Medicine Medicare: Medicare Enrolled Practice Location: 5158 Black Hawk Rd, Aberdeen Proving Ground, MD 21010 Phone: 410-436-5127 | |
Dr. William Arthur Rice, MD, MPH, MHA Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2501 Oakington St, Kirk U.s. Army Health Clinic, Aberdeen Proving Ground, MD 21005 Phone: 410-278-1727 Fax: 410-278-1783 | |
Dr. Steven Brian Cersovsky, MD, MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 5158 Black Hawk Rd, Aberdeen Proving Ground, MD 21010 Phone: 410-436-4655 |